Market Indices
Sector Heatmap
IPSC — Century Therapeutics, Inc. Common Stock
NasdaqCentury Therapeutics, Inc. Common Stock
- O
- 1.58
- H
- 1.59
- L
- 1.45
- V
- 771.33K
IPSC — Latest News & Headlines
10 StoriesDiabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. - Stock Titan
Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. Stock Titan
Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) - Seeking Alpha
Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) Seeking Alpha
Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch - stocktwits.com
Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch stocktwits.com
Century Therapeutics presents preclinical data for T1D therapy By Investing.com - Investing.com South Africa
Century Therapeutics presents preclinical data for T1D therapy By Investing.com Investing.com South Africa
Century Therapeutics appoints Truitt. Century Therapeutics stock has USD 309.6 million value. - AD HOC NEWS
Century Therapeutics appoints Truitt. Century Therapeutics stock has USD 309.6 million value. AD HOC NEWS
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) The Manila Times
Two new hires at Fate Therapeutics get stock awards that vest over four years if they stay - Stock Titan
Two new hires at Fate Therapeutics get stock awards that vest over four years if they stay Stock Titan
After 16 years, Evotec's science chief is stepping down - Stock Titan
After 16 years, Evotec's science chief is stepping down Stock Titan
Evotec stock after-hours at EUR 2.92: minus 4.26 percent - AD HOC NEWS
Evotec stock after-hours at EUR 2.92: minus 4.26 percent AD HOC NEWS
Century Therapeutics advances CNTY-813 islet therapy program - TipRanks
Century Therapeutics advances CNTY-813 islet therapy program TipRanks